A venture capital firm based in the Mountain West has approximately $300 million in total assets available for investment. The firm typically makes equity investments in 3 to 4 companies every year, and it has flexibility in terms of capital structures. The average first investment in a company is $2 million- $3 million, though it can invest more or less, depending on the opportunity. The firm prefers to invest in seed and series A (early-stage) companies as an initial investment in a company, though it sometimes makes a first investment in a series B or C round. The firm primarily invests in US-based companies, but it will also consider global companies with a US presence.
The firm is currently looking for investment opportunities in medical devices, biopharma and diagnostics. The firm generally makes investments in product-focused companies in pre-clinical stages with prototypes or other available proof-of-concept work completed. It generally likes to invest in companies that can reach the market with the capital raised from this round of financing. The firm prefers device companies with a 510(k) pathway for regulatory approval, and it will opportunistically consider companies with PMA devices.
The firm seeks to invest in small, early-stage companies with a lean but strong and qualified management / execution team.
If you are interested in more information about this investor and other investors tracked by LSN, please email firstname.lastname@example.org